BIO

Jörg-Michael Rupp is a leader in the global biopharmaceutical market who has focused his career on increasing patient access to innovation. His goal is to provide better health outcomes to a greater number of patients, faster and at lower costs to society. His passion lies in strengthening global healthcare systems in collaboration with key stakeholders, including public administrators, healthcare workers, and most importantly, patients and their representatives.

He has lived and worked in seven countries on four continents.

ROCHE / PHARMA INTERNATIONAL DIRECTOR

Jörg is responsible for Roche’s pharmaceutical operations in over 100 countries worldwide, including Europe, Latin America, Asia, the Middle East, and Africa. During his over 30 years at Roche, he has held various senior-level positions, including General Manager in Israel, South Africa, and Greece, as well as Regional Director for Latin America. He also served as Franchise Director, overseeing the late-stage development and commercialization of one of Roche’s most well-known anticancer drugs, Avastin.

INTERPHARMA / PRESIDENT

Interpharma is an association of the Swiss pharmaceutical industry based on scientific research, comprising 23 companies. The association’s members represent 90 percent of the Swiss market for innovative and patented drugs and invest 6.5 billion Swiss francs annually in research and development in the country. Interpharma is committed to promoting an effective, high-quality healthcare system that provides patients with rapid access to innovative treatment methods and the best possible care.

CITY CANCER CHALLENGE / BOARD CHAIR

Initiated by the Union for International Cancer Control (UICC), the City Cancer Challenge is a multisectoral foundation working to build a world where high-quality and optimal cancer care is available to all patients. The organization pursues its mission by collaborating with cities, enabling them to take a leading role in designing, planning, and implementing diverse solutions in cancer care.